跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACAMPROSATE VIATRIS acamprosate calcium 333 mg enteric coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ACAMPROSATE VIATRIS acamprosate calcium 333 mg enteric coated tablet blister pack
Approved
STANDARD
ACAMPROSATE VIATRIS acamprosate calcium 333 mg enteric coated tablet blister pack
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
d4e5be4f05665a93
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
d4e5be4f05665a93
Product Name
ACAMPROSATE VIATRIS acamprosate calcium 333 mg enteric coated tablet blister pack
Artg Id
298641
Artg Name
ACAMPROSATE VIATRIS acamprosate calcium 333 mg enteric coated tablet blister pack
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2018-03-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/18b7eadc6784569627f2ba5eca5b7e8e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/ab87ffbbe49472cb55f7424467347fbb.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
d4e5be4f05665a93
Type
Standard
Back to TGA Approvals